Pfenex Expects To Be Alone With Teriparatide

Not Expecting Teva Entry Until Later Next Year

Puzzle_Optimism
Pfenex believes it could get a significant head start with its rival to Lilly's Forteo teriparatide brand in the US • Source: Shutterstock

More from Products

More from Generics Bulletin